Specific targeting of protein–DNA complexes by dna‐reactive drugs (+)‐CC‐1065 and pluramycins
Identifieur interne : 003F24 ( Main/Exploration ); précédent : 003F23; suivant : 003F25Specific targeting of protein–DNA complexes by dna‐reactive drugs (+)‐CC‐1065 and pluramycins
Auteurs : Douglas Henderson [États-Unis] ; Laurence H. Hurley [États-Unis]Source :
- Journal of Molecular Recognition [ 0952-3499 ] ; 1996-03.
Abstract
To gain insight into the interactions between transcriptional factor proteins and DNA, the DNA‐reactive drugs (+)‐CC‐1065 and pluramycin were used to target specific protein–DNA complexes. The structural features of the complex between the transcriptional activator Sp1 and the 21‐base‐pair repeat of the early promoter region of SV40 DNA were examined using hydroxyl‐radical footprinting; (+)‐CC‐1065, a sequence‐specific minor groove bending probe; and circularization experiments. The results show that the 21‐base‐pair repeat region has an intrinsically in‐phase bent structure that is stabilized upon saturation Sp1 binding by protein–DNA and protein–protein interactions to produce a looping structure. The intercalating drug pluramycin was used to probe the structural details of the interaction between the TATA binding protein (TBP) and the TATA box DNA sequence. TBP, which directs initiation of RNA transcription, exhibits two‐fold symmetry and apparently interacts with the TATA box in a symmetrical fashion. However, the interaction results in an asymmetric effect, in that transcription is initiated only in the downstream direction. Using pluramycin as a probe, it was determined that TBP binding to the human myoglobin TATA sequences enhances pluramycin reactivity at a site immediately downstream of the TATA box. The implications on transcriptional control of ternary complexes comprised of transcriptional factors, DNA, and DNA‐reactive compounds will be presented.
Url:
DOI: 10.1002/(SICI)1099-1352(199603)9:2<75::AID-JMR247>3.0.CO;2-4
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001C04
- to stream Istex, to step Curation: 001C04
- to stream Istex, to step Checkpoint: 001660
- to stream Main, to step Merge: 003F79
- to stream Main, to step Curation: 003F24
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Specific targeting of protein–DNA complexes by dna‐reactive drugs (+)‐CC‐1065 and pluramycins</title>
<author><name sortKey="Henderson, Douglas" sort="Henderson, Douglas" uniqKey="Henderson D" first="Douglas" last="Henderson">Douglas Henderson</name>
</author>
<author><name sortKey="Hurley, Laurence H" sort="Hurley, Laurence H" uniqKey="Hurley L" first="Laurence H." last="Hurley">Laurence H. Hurley</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:0AD951B4B04475864C85137A932A3D669ACD46BE</idno>
<date when="1996" year="1996">1996</date>
<idno type="doi">10.1002/(SICI)1099-1352(199603)9:2<75::AID-JMR247>3.0.CO;2-4</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-SX5TGKZ0-D/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001C04</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001C04</idno>
<idno type="wicri:Area/Istex/Curation">001C04</idno>
<idno type="wicri:Area/Istex/Checkpoint">001660</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001660</idno>
<idno type="wicri:doubleKey">0952-3499:1996:Henderson D:specific:targeting:of</idno>
<idno type="wicri:Area/Main/Merge">003F79</idno>
<idno type="wicri:Area/Main/Curation">003F24</idno>
<idno type="wicri:Area/Main/Exploration">003F24</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">Specific targeting of protein–DNA complexes by dna‐reactive drugs (+)‐CC‐1065 and pluramycins</title>
<author><name sortKey="Henderson, Douglas" sort="Henderson, Douglas" uniqKey="Henderson D" first="Douglas" last="Henderson">Douglas Henderson</name>
<affiliation wicri:level="4"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Drug Dynamics Institute, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712</wicri:regionArea>
<orgName type="university">Université du Texas à Austin</orgName>
<placeName><settlement type="city">Austin (Texas)</settlement>
<region type="state">Texas</region>
</placeName>
</affiliation>
<affiliation wicri:level="4"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Correspondence address: Drug Dynamics Institute, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712</wicri:regionArea>
<orgName type="university">Université du Texas à Austin</orgName>
<placeName><settlement type="city">Austin (Texas)</settlement>
<region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hurley, Laurence H" sort="Hurley, Laurence H" uniqKey="Hurley L" first="Laurence H." last="Hurley">Laurence H. Hurley</name>
<affiliation wicri:level="4"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Drug Dynamics Institute, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712</wicri:regionArea>
<orgName type="university">Université du Texas à Austin</orgName>
<placeName><settlement type="city">Austin (Texas)</settlement>
<region type="state">Texas</region>
</placeName>
</affiliation>
<affiliation wicri:level="4"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Correspondence address: Drug Dynamics Institute, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712</wicri:regionArea>
<orgName type="university">Université du Texas à Austin</orgName>
<placeName><settlement type="city">Austin (Texas)</settlement>
<region type="state">Texas</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Journal of Molecular Recognition</title>
<title level="j" type="alt">JOURNAL OF MOLECULAR RECOGNITION</title>
<idno type="ISSN">0952-3499</idno>
<idno type="eISSN">1099-1352</idno>
<imprint><biblScope unit="vol">9</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="75">75</biblScope>
<biblScope unit="page" to="87">87</biblScope>
<biblScope unit="page-count">13</biblScope>
<publisher>John Wiley & Sons, Ltd.</publisher>
<pubPlace>Chichester, UK</pubPlace>
<date type="published" when="1996-03">1996-03</date>
</imprint>
<idno type="ISSN">0952-3499</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0952-3499</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">To gain insight into the interactions between transcriptional factor proteins and DNA, the DNA‐reactive drugs (+)‐CC‐1065 and pluramycin were used to target specific protein–DNA complexes. The structural features of the complex between the transcriptional activator Sp1 and the 21‐base‐pair repeat of the early promoter region of SV40 DNA were examined using hydroxyl‐radical footprinting; (+)‐CC‐1065, a sequence‐specific minor groove bending probe; and circularization experiments. The results show that the 21‐base‐pair repeat region has an intrinsically in‐phase bent structure that is stabilized upon saturation Sp1 binding by protein–DNA and protein–protein interactions to produce a looping structure. The intercalating drug pluramycin was used to probe the structural details of the interaction between the TATA binding protein (TBP) and the TATA box DNA sequence. TBP, which directs initiation of RNA transcription, exhibits two‐fold symmetry and apparently interacts with the TATA box in a symmetrical fashion. However, the interaction results in an asymmetric effect, in that transcription is initiated only in the downstream direction. Using pluramycin as a probe, it was determined that TBP binding to the human myoglobin TATA sequences enhances pluramycin reactivity at a site immediately downstream of the TATA box. The implications on transcriptional control of ternary complexes comprised of transcriptional factors, DNA, and DNA‐reactive compounds will be presented.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Texas</li>
</region>
<settlement><li>Austin (Texas)</li>
</settlement>
<orgName><li>Université du Texas à Austin</li>
</orgName>
</list>
<tree><country name="États-Unis"><region name="Texas"><name sortKey="Henderson, Douglas" sort="Henderson, Douglas" uniqKey="Henderson D" first="Douglas" last="Henderson">Douglas Henderson</name>
</region>
<name sortKey="Henderson, Douglas" sort="Henderson, Douglas" uniqKey="Henderson D" first="Douglas" last="Henderson">Douglas Henderson</name>
<name sortKey="Hurley, Laurence H" sort="Hurley, Laurence H" uniqKey="Hurley L" first="Laurence H." last="Hurley">Laurence H. Hurley</name>
<name sortKey="Hurley, Laurence H" sort="Hurley, Laurence H" uniqKey="Hurley L" first="Laurence H." last="Hurley">Laurence H. Hurley</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003F24 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003F24 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:0AD951B4B04475864C85137A932A3D669ACD46BE |texte= Specific targeting of protein–DNA complexes by dna‐reactive drugs (+)‐CC‐1065 and pluramycins }}
This area was generated with Dilib version V0.6.33. |